Downloads
Title
Source name
Date

FDA Approves Blinatumomab for Adult and Pediatric Patients With B-ALL

The FDA approved blinatumomab for treatment of patients with CD19-positive Philadelphia chromosome-negative B-cell precursor acute lymphoblastic leukemia.

Pharmacy Times
18 Jun 2024

FDA Approves Durvalumab Plus Chemotherapy to Treat Endometrial Cancer

Durvalumab plus carboplatin and paclitaxel, continued with durvalumab monotherapy, decreased the risk of disease progression or death by 58%.

Pharmacy Times
18 Jun 2024

Study: Mim8 Shows Reductions in Treated Bleeds for Patients With Hemophilia A

Mim8 had a safe and well-tolerated profile, with no deaths or thrombotic events reported for patients with hemophilia A.

Pharmacy Times
18 Jun 2024

FDA Approves the Intravenous Immunoglobulin G Yimmugo to Treat Primary Immunodeficiencies

With this approval, Yimmugo is the first approved product from the Biotest Next Level production facility.

Pharmacy Times
18 Jun 2024

Expert: Individualized Gender-Affirming Care and Support is Essential for LGBTQ+ Patients

Creating a supportive environment and staying informed on the latest research can be significant when supporting patients in the LGBTQ+ community, notes Olivia Buckoski, PharmD, AAHIVP, HIVPCP.

Pharmacy Times
17 Jun 2024

OTC Guide: 28 Years Strong

Since 1997, Pharmacy Times has compiled these results to collect the most up-to-date information about which brands pharmacists recommend most often to patients.

Pharmacy Times
17 Jun 2024

CDC Evaluates Concerns of Guillain-Barré Syndrome Following RSV Vaccination

Data show that the estimated rate of Guillain-Barré syndrome (GBS) after receiving an RSV vaccine was 5.0 among individuals aged 60 years and older, with 1.5 reports per million doses of both vaccines.

Pharmacy Times
17 Jun 2024

June 2024 Products Column

Pharmacy Times offers the latest news and insights for the pharmacy professional and solutions that impact the everyday practice of pharmacy.

Pharmacy Times
17 Jun 2024

Cassandra Perkey, PharmD, BCOP

Pharmacy Times offers the latest news and insights for the pharmacy professional and solutions that impact the everyday practice of pharmacy.

Pharmacy Times
17 Jun 2024

Brooke Peters, PharmD, BCOP

Pharmacy Times offers the latest news and insights for the pharmacy professional and solutions that impact the everyday practice of pharmacy.

Pharmacy Times
17 Jun 2024

Bradley Winegar, PharmD

Pharmacy Times offers the latest news and insights for the pharmacy professional and solutions that impact the everyday practice of pharmacy.

Pharmacy Times
17 Jun 2024

Manale Maksour, PharmD, BCPS

Pharmacy Times offers the latest news and insights for the pharmacy professional and solutions that impact the everyday practice of pharmacy.

Pharmacy Times
17 Jun 2024

Jenny Li, PharmD, BCPS, BCOP

Pharmacy Times offers the latest news and insights for the pharmacy professional and solutions that impact the everyday practice of pharmacy.

Pharmacy Times
17 Jun 2024

Melody Chang, MBA, Rph, BCOP

Pharmacy Times offers the latest news and insights for the pharmacy professional and solutions that impact the everyday practice of pharmacy.

Pharmacy Times
17 Jun 2024

Drug Shortages in Community Oncology: Ensuring Access to Chemotherapy

Persistent chemotherapy drug shortages challenge oncology providers. American Oncology Network employs a drug shortage committee for organized shortage management that involves pharmacists and interdisciplinary stakeholders.

Pharmacy Times
17 Jun 2024

Pharmacist Spotlight: Amina Abubakar, PharmD, AAHIVP

Pharmacy Times offers the latest news and insights for the pharmacy professional and solutions that impact the everyday practice of pharmacy.

Pharmacy Times
17 Jun 2024

Children Exposed to Weed and Tree Pollen in Urban Areas May Experience Increased Risk of Asthma Onset

The study results also found that exposure to tree canopy area may protect children from asthma development; however, efficacy decreased as weed pollen exposure increased.

Pharmacy Times
15 Jun 2024

All News | Page 1277

Pharmacy Times offers the latest news and insights for the pharmacy professional and solutions that impact the everyday practice of pharmacy.

Pharmacy Times
15 Jun 2024

Zanubrutinib Emerges as Potential First-Line Therapy in Patients with High-Risk CLL/SLL

Zanubrutinib shows potential in treating patients with treatment-naïve high-risk chronic lymphocytic leukemia and/or small lymphocytic lymphoma with del(17p) and/or TP53 mutation.

Pharmacy Times
15 Jun 2024

OTC Guide 2024: Leading The Way

OTC products are cost-effective and offer patients a convenient self-treatment option.

Pharmacy Times
15 Jun 2024

Pharmacogenomics Are A Cornerstone of the Precision Medicine Approach

Precision medicine takes a proactive stance by leveraging genetic insights to guide treatment decisions from the outset.

Pharmacy Times
14 Jun 2024

Growing Use of Herbal Medicine in Cancer Patients Highlights Risks, Communication Gaps

As patients take more proactive roles in their health, they may feel too intimidated to discuss herbal medicinal use with their providers or may be unaware of potential interactions with their drug therapies.

Pharmacy Times
14 Jun 2024

Trametinib Demonstrates Potential as a First-Line Treatment for Pediatric Patients with JMML

Trametinib may become an alternative treatment to hematopoietic stem cell transplantation in patients with relapsed or refractory juvenile myelomonocytic leukemia (JMML).

Pharmacy Times
14 Jun 2024

Brentuximab Vedotin Shows 37% Reduction in Risk of Death for DLBCL

Brentuximab vedotin in combination with lenalidomide and rituximab had a favorable safety profile for patients with relapsed/refractory diffuse large B-cell lymphoma.

Pharmacy Times
14 Jun 2024

Study Finds Similarities Between SB16 and Denosumab for Osteoporosis Treatment Up to 18 Months

The new findings were presented as an oral presentation at the 2024 European Calcified Tissue Society Congress, held from May 25, 2024, to May 28, 2024.

Pharmacy Times
14 Jun 2024
We use cookies to enhance your browsing experience. By continuing to use our website you agree to our policies Read the policyAccept